Therefore, GHRP-2 is best viewed as a tool to support body recomposition (reducing fat while building or maintaining muscle) as part of a comprehensive strategy, not as a standalone fat loss drug
Shifting doses by a single day can alter peak and trough concentrations, potentially affecting appetite suppression, glucose control, and gastrointestinal tolerability
Chronic conditions like Long COVID and ME/CFS can deplete glutathione, driving severe fatigue and brain fog
Tirzepatide counteracts this by signaling fullness to the hypothalamus, but the effect may feel muted if steroid-driven hunger is strong
If you fall into both groups, understanding how these medications interact is essential for your safety
A personal or family history of medullary thyroid cancer or MEN2 is a class contraindication